IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Rhenman & Partners Asset Management AB

Q2 2026 Holdings

Filed 2026-08-13 | 99 holdings | $1.1B | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↑Shares% Portfolio
TG Therapeutics Inc(TGTX)COM88322Q108$274.7K5,0000.0%
Tandem Diabetes Care Inc(TNDM)COM NEW875372203$301.8K20,0000.0%
10X Genomics Inc(TXG)CL A COM88025U109$325.9K8,5000.0%
Agilon Health Inc(AGL)COM NEW00857U206$535.9K5,0000.1%
Alphatec Hldgs Inc(ATEC)COM NEW02081G201$735.3K85,0000.1%
Minimed Group Inc(MMED)COM60365F109$822.3K55,0000.1%
Novocure LTD(NVCR)ORD SHSG6674U108$1.1M70,0000.1%
Privia Health Group Inc(PRVA)COM74276R102$1.3M50,0000.1%
Doximity Inc(DOCS)CL A26622P107$1.6M76,1070.1%
Xenon Pharmaceuticals Inc(XENE)COM98420N105$2.0M33,2500.2%
Stoke Therapeutics Inc(STOK)COM86150R107$2.1M64,5000.2%
Ocular Therapeutix Inc(OCUL)COM67576A100$2.2M225,0000.2%
Steris PLC(STE)SHS USDG8473T100$2.4M11,5000.2%
Bicara Therapeutics Inc(BCAX)COM055477103$2.6M88,1500.2%
Veeva SYS Inc(VEEV)CL A COM922475108$3.1M17,3000.3%
Vericel Corp(VCEL)COM92346J108$3.1M70,0000.3%
MBX Biosciences Inc(MBX)COM55287L101$3.4M62,0000.3%
Waystar Hldg Corp(WAY)COM946784105$3.7M178,5660.3%
Cooper COS Inc(COO)COM216648501$3.9M54,0000.4%
Ascendis Pharma A/S(ASND)ORD SHSK08588103$4.0M15,0000.4%
Sionna Therapeutics Inc(SION)COM829401108$4.3M97,1000.4%
Amgen Inc(AMGN)COM031162100$4.3M11,9000.4%
Madrigal Pharmaceuticals Inc(MDGL)COM558868105$4.3M8,0500.4%
Medpace Hldgs Inc(MEDP)COM58506Q109$4.5M8,5000.4%
Denali Therapeutics Inc(DNLI)COM24823R105$4.6M179,0000.4%
AMN Healthcare Svcs Inc(AMN)COM001744101$4.7M144,4660.4%
Ionis Pharmaceuticals Inc(IONS)COM462222100$4.7M59,9000.4%
The Cigna Group(CI)COM125523100$4.8M17,4000.5%
Viking Therapeutics Inc(VKTX)COM92686J106$5.0M128,0000.5%
Molina Healthcare Inc(MOH)COM60855R100$5.0M21,8570.5%
Alnylam Pharmaceuticals Inc(ALNY)COM02043Q107$5.2M17,2000.5%
Cardinal Health Inc(CAH)COM14149Y108$5.3M22,5000.5%
Astrana Health Inc(ASTH)COM NEW03763A207$5.5M118,8880.5%
Stevanato Group S P A(STVN)ORD SRST9224W109$5.5M305,9720.5%
Krystal Biotech Inc(KRYS)COM501147102$6.1M16,3250.6%
Erasca Inc(ERAS)COM29479A108$6.4M349,0000.6%
Insulet Corp(PODD)COM45784P101$6.4M42,0000.6%
Kura Oncology Inc(KURA)COM50127T109$6.5M591,5000.6%
Bridgebio Pharma Inc(BBIO)COM10806X102$6.8M91,1000.6%
Iovance Biotherapeutics Inc(IOVA)COM462260100$7.1M1,705,3270.7%
Moonlake Immunotherapeutics(MLTX)CLASS A ORD61559X104$7.5M384,8000.7%
Encompass Health Corp(EHC)COM29261A100$7.5M74,2630.7%
Oruka Therapeutics Inc(ORKA)COM687604108$7.6M80,0000.7%
Structure Therapeutics Inc(GPCR)SPONSORED ADS86366E106$7.8M145,1000.7%
Procept Biorobotics Corp(PRCT)COM74276L105$7.8M345,0000.7%
Dianthus Therapeutics Inc(DNTH)COM252828108$8.4M86,1270.8%
Abbott Laboratories(ABT)COM002824100$8.7M96,0000.8%
Alkermes PLC(ALKS)SHSG01767105$9.7M185,2500.9%
Nektar Therapeutics(NKTR)COM NEW640268306$9.9M141,2500.9%
Agilent Technologies Inc(A)COM00846U101$10.0M75,0000.9%
Page 1 of 2Next